Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT on merger of FocusVision and Confirmit
Mandate

Vinge advises EQT on merger of FocusVision and Confirmit

January 08, 2021 Employment and Benefits Banking and Finance EU, Competition and Regulatory M&A

The Nordic-based PE-forms EQT and Verdance intends to merger their respective portfolio companies FocusVision and Confirmit.

FocusVision was acuiered by EQT 201t and provides software and services for market research. Confirmit was acquired by Verdane 2019 and provides solutions for, inter alia, customer experience and market research. The merger is subject to customary regulatory approvals. 

Vinge’s team consisted of partners Christina Kokko (M&A), Marcus Glader (EU & Competition) and Albert Wållgren (Banking & Finance) and associates Stina Bengtsson (M&A), Pauline Lagerstrand, (Banking & Finance), Ebba Svenburg (Employment), Emma Johansson, Sebastian Örndahl, Anna Grigorian, Xandra Ståhlberg and Alice Noguier (EU & Competition).

Related

Vinge advises Stendörren in connection with issuance of green capital securities

 Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green capital securities in an amount of SEK 400 million (within a framework of SEK 800 million).
May 07, 2026

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

 Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Fazer in connection with its acquisition of Aroma

 Fazer has entered into an agreement to acquire Konfektyrfabriken Aroma AB, a Swedish confectionery manufacturer known for its classic candy products such as Geléhallon, Hallonbåtar, Röda Hjärtan and Gräddkola. The acquisition strengthens Fazer's position in the Swedish confectionery market, particularly within pick & mix, packed candy, and seasonal products. The acquisition is subject to customary regulatory approvals.
May 06, 2026